Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder
Clinical trial NCT06093451 · UNKNOWN
Trial details
- NCT number
- NCT06093451
- Sponsor
- Temple University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2024-07-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.